Science Explorer Back to mapMap
Discussion
Researcher · Australian National University · Australia

Christopher Carl Goodnow

Christopher Carl Goodnow publishes mostly in Immunology, Molecular Biology and Genetics, on topics such as T-cell and B-cell Immunology, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.

ORCID 0000-0001-5296-6155 OpenAlex
World rank
#40,721
of 7,710,434 ranked researchers
Rank in Australia
#1,217
of 140,210
Works
419
Citations
46k
Citations per work
109.2
h-index
105
i10-index 278Top 0.3% in Immunology
Christopher Carl Goodnow

What does Christopher Carl Goodnow research?

Christopher Carl Goodnow's work is mostly in Immunology and Microbiology (50%), Biochemistry, Genetics and Molecular Biology (22%), Medicine (8%).

Life Sciences: 303 works · 72.3% of their workImmunology and Microbiology: 210 works · 50.0% of their workImmunology: 210 works · 50.0% of their workBiochemistry, Genetics and Molecular Biology: 93 works · 22.3% of their workMolecular Biology: 52 works · 12.3% of their workGenetics: 31 works · 7.3% of their workCancer Research: 11 works · 2.7% of their workEverything else: 80 works · 19.2% of their workHealth Sciences: 36 works · 8.5% of their workMedicine: 36 works · 8.5% of their workRadiology, Nuclear Medicine and Imaging: 20 works · 4.8% of their workOncology: 16 works · 3.7% of their workTHEIR WORKChristopher CarlGoodnow419works
Life Sciences72%Health Sciences8%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology21050.0%
    2. Biochemistry, Genetics and Molecular Biology9322.3%
  2. Everything else8019.2%
    1. Medicine368.5%
  1. 1Immunology50% of their works
  2. 2Molecular Biology12% of their works
  3. 3Genetics7% of their works
  4. 4Radiology, Nuclear Medicine and Imaging5% of their works
  5. 5Oncology4% of their works
  6. 6Cancer Research3% of their works

Research topics

Which keywords describe Christopher Carl Goodnow's research?

The keywords of their largest research topics: Autoimmunity, Foxp3, TGF-ß, Natural Killer Cells, NK Cell Recognition, Cancer Immunotherapy, Dendritic Cells and Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Autoimmunity2502 topics
  2. Foxp32101 topic
  3. TGF-ß2101 topic
  4. NK Cell Recognition1761 topic
  5. Natural Killer Cells1761 topic
  6. Cancer Immunotherapy862 topics
  7. Dendritic Cells651 topic
  8. Immunity651 topic
  9. Immunotherapy612 topics
  10. Fc Receptors541 topic
  11. Therapeutic Antibodies541 topic
  12. Genetic Mutations531 topic
  13. Primary Immunodeficiency531 topic
  14. Genetics401 topic
  15. Type 1 Diabetes401 topic
  16. Pattern Recognition Receptors241 topic
  17. Toll-like Receptors241 topic
  18. CAR T Cells211 topic
  19. Chimeric Antigen Receptor211 topic

Where does Christopher Carl Goodnow work?

Christopher Carl Goodnow's main affiliation in the publication record is Australian National University, Australia.

How many publications and citations does Christopher Carl Goodnow have?

OpenAlex counts 419 works and 45,771 citations for Christopher Carl Goodnow, an h-index of 105, ranking #40,721 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Christopher Carl Goodnow. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.